BML, Inc. (TYO:4694)

Market Cap	127.75B
Revenue (ttm)	143.19B
Net Income (ttm)	6.26B
Shares Out	39.01M
EPS (ttm)	160.55
PE Ratio	20.40
Forward PE	19.15
Dividend	120.00 (3.66%)
Ex-Dividend Date	Mar 28, 2025

Volume	43,400
Average Volume	65,035
Open	3,265.00
Previous Close	3,275.00
Day's Range	3,265.00 - 3,315.00
52-Week Range	2,592.00 - 3,400.00
Beta	0.26
RSI	62.41
Earnings Date	Aug 8, 2025

About BML, Inc.

BML, Inc. provides laboratory testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; special laboratory test, including RIA, cellular, immunological, and DNA analysis; and microbiological tests for medical and pharmaceutical societies and organizations; laboratory tests in tumorology, infectious disease, diabetes, hypertension, allergy, and genetic studies, as well as develops Frontier and Symphony automation systems, which automate pre-processing procedures from...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1955
• Employees: 4,558
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4694

Financial Performance

In 2024, BML, Inc.'s revenue was 143.19 billion, an increase of 3.79% compared to the previous year's 137.96 billion. Earnings were 6.26 billion, an increase of 3.80%.